WO2002072823A3 - Regulation de recepteur complexe a la proteine g humain - Google Patents

Regulation de recepteur complexe a la proteine g humain Download PDF

Info

Publication number
WO2002072823A3
WO2002072823A3 PCT/EP2002/001606 EP0201606W WO02072823A3 WO 2002072823 A3 WO2002072823 A3 WO 2002072823A3 EP 0201606 W EP0201606 W EP 0201606W WO 02072823 A3 WO02072823 A3 WO 02072823A3
Authority
WO
WIPO (PCT)
Prior art keywords
disorders
human
protein
coupled receptor
reagents
Prior art date
Application number
PCT/EP2002/001606
Other languages
English (en)
Other versions
WO2002072823A2 (fr
Inventor
Alex Smolyar
Original Assignee
Bayer Ag
Alex Smolyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Alex Smolyar filed Critical Bayer Ag
Priority to DE60226414T priority Critical patent/DE60226414D1/de
Priority to EP02719843A priority patent/EP1364026B1/fr
Priority to AU2002250949A priority patent/AU2002250949A1/en
Priority to US10/467,164 priority patent/US20040106123A1/en
Publication of WO2002072823A2 publication Critical patent/WO2002072823A2/fr
Publication of WO2002072823A3 publication Critical patent/WO2002072823A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des réactifs qui régulent le récepteur complexé à la protéine G (GPCR) humain et des réactifs qui relient des produits géniques au GPCR humain pouvant jouer un rôle dans la prévention, l'amélioration, ou la correction des dysfonctionnements ou des maladies comprenant, mais de manière non exclusive, la broncho-pneumopathie chronique obstructive (BPCO), les troubles cardio-vasculaires, le cancer, les troubles urinaires, l'obésité, le diabète, les troubles du système nerveux central, les maladies du foie, les maladies du rein, les troubles affectant les organes de sécrétion, l'asthme, une maladie métabolique et des troubles hématologiques.
PCT/EP2002/001606 2001-02-20 2002-02-15 Regulation de recepteur complexe a la proteine g humain WO2002072823A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE60226414T DE60226414D1 (de) 2001-02-20 2002-02-15 Menschlicher g-protein gekoppelter rezeptor
EP02719843A EP1364026B1 (fr) 2001-02-20 2002-02-15 Recepteur complexe a la proteine g humain
AU2002250949A AU2002250949A1 (en) 2001-02-20 2002-02-15 Human g protein-coupled receptor
US10/467,164 US20040106123A1 (en) 2001-02-20 2002-02-15 Regulation of human g protein-coupled receptor

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26941001P 2001-02-20 2001-02-20
US60/269,410 2001-02-20
US32380901P 2001-09-19 2001-09-19
US60/323,809 2001-09-19

Publications (2)

Publication Number Publication Date
WO2002072823A2 WO2002072823A2 (fr) 2002-09-19
WO2002072823A3 true WO2002072823A3 (fr) 2003-08-28

Family

ID=26953678

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/001606 WO2002072823A2 (fr) 2001-02-20 2002-02-15 Regulation de recepteur complexe a la proteine g humain

Country Status (7)

Country Link
US (1) US20040106123A1 (fr)
EP (1) EP1364026B1 (fr)
AT (1) ATE394487T1 (fr)
AU (1) AU2002250949A1 (fr)
DE (1) DE60226414D1 (fr)
ES (1) ES2305229T3 (fr)
WO (1) WO2002072823A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60142079D1 (de) 2000-11-17 2010-06-17 Banyu Pharma Co Ltd Verfahren zur suche nach komponenten, in dem das guanosintriphosphat- (gtp-) bindungsprotein gekoppeltes rezeptorprotein bg37 verwendet wird
WO2004043468A1 (fr) * 2002-11-12 2004-05-27 Takeda Pharmaceutical Company Limited Procede de criblage
AU2003298111A1 (en) * 2002-11-22 2004-06-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37)
KR100693528B1 (ko) * 2004-10-29 2007-03-14 주식회사 팬택 전원 지연 인가 기능을 가지는 무선통신 단말기
WO2023230570A2 (fr) * 2022-05-25 2023-11-30 Flagship Pioneering Innovations Vii, Llc Compositions et procédés de modulation de pilotes génétiques
WO2023230578A2 (fr) * 2022-05-25 2023-11-30 Flagship Pioneering Innovations Vii, Llc Compositions et procédés de modulation de facteurs de circulation
WO2023230566A2 (fr) * 2022-05-25 2023-11-30 Flagship Pioneering Innovations Vii, Llc Compositions et procédés de modulation de cytokines

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064942A1 (fr) * 1999-04-27 2000-11-02 Smithkline Beecham Corporation Axor-27, recepteur couple a une proteine g
WO2001077325A1 (fr) * 2000-04-12 2001-10-18 Takeda Chemical Industries, Ltd. Nouvelle proteine de recepteur couple aux proteines g et adn de celle-ci

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119493A1 (en) * 2000-07-21 2002-08-29 Glucksmann Maria Alexandra 65494, a novel human G-protein-coupled receptor family member and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000064942A1 (fr) * 1999-04-27 2000-11-02 Smithkline Beecham Corporation Axor-27, recepteur couple a une proteine g
WO2001077325A1 (fr) * 2000-04-12 2001-10-18 Takeda Chemical Industries, Ltd. Nouvelle proteine de recepteur couple aux proteines g et adn de celle-ci

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE NCBI [online] 8 November 2000 (2000-11-08), XP002232674, Database accession no. AC021016 *
THE SANGER CENTRE (UK) AND THE WASHINGTON UNIVERSITY GENOME SEQUENCING CENTER (USA): "Toward a complete human genome sequence", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 8, no. 11, November 1998 (1998-11-01), pages 1097 - 1108, XP002169000, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
WO2002072823A2 (fr) 2002-09-19
ATE394487T1 (de) 2008-05-15
EP1364026B1 (fr) 2008-05-07
AU2002250949A1 (en) 2002-09-24
EP1364026A2 (fr) 2003-11-26
ES2305229T3 (es) 2008-11-01
US20040106123A1 (en) 2004-06-03
DE60226414D1 (de) 2008-06-19

Similar Documents

Publication Publication Date Title
WO2001087929A3 (fr) Regulation de recepteur couple aux proteines g de type dopamine humain
WO2002072823A3 (fr) Regulation de recepteur complexe a la proteine g humain
WO2002036754A3 (fr) Regulation de la lipase acide lysosomale humaine
WO2002072824A3 (fr) Regulation du canal potentiel humain du recepteur transitoire humain
WO2002059302A3 (fr) Regulation du recepteur humain couple a la proteine g semblable a serotonine
WO2001092297A3 (fr) Regulation du recepteur couple a la proteine g analogue du lgr-4 humain
WO2002006453A3 (fr) Regulation de protease a serine humaine de type desc1
WO2004009803A3 (fr) Regulation de l'hepsine humaine
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2003052088A3 (fr) Regulation de la sialyltransferase humaine
WO2002032958A3 (fr) Regulation de l'immunorecepteur des cellules dendritiques humaines
WO2003064469A3 (fr) Regulation de la proteine du type de recepteur hematopoietique humain
WO2002101043A3 (fr) Regulation du recepteur ta4 humain
WO2002099107A3 (fr) Regulation du recepteur ta5 humain
WO2002042435A3 (fr) Regulation de la tyrosine phosphatase humaine
WO2003000903A3 (fr) Regulation de serine/threonine proteine kinase humaine de type nek
WO2002031125A3 (fr) Regulation de l'enzyme semblable a phospholipase a2 humaine
WO2002033056A3 (fr) Regulation de serine-threonine kinase humaine
WO2002031160A3 (fr) Regulation de l'enzyme de type a2 phospholipase humaine
WO2002031162A3 (fr) Regulation de l'enzyme du type phospholipase a2 humaine
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2002099106A3 (fr) Regulation de gpcr de type secretine humaine
WO2002051989A3 (fr) Regulation de la 4-nitrophenylphosphatase humaine
WO2002081704A3 (fr) Regulation de la proteine de type proteine kinase humaine
WO2002077217A3 (fr) Regulation de proteine humaine du type phosphatase 7 a specificite double (dspp7)

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2002719843

Country of ref document: EP

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002719843

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10467164

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2002719843

Country of ref document: EP